Cited 9 time in
Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Min Seo | - |
| dc.contributor.author | Chang, Jee Suk | - |
| dc.contributor.author | Kim, Kyubo | - |
| dc.contributor.author | Kim, Jin Hee | - |
| dc.contributor.author | Kim, Tae Hyung | - |
| dc.contributor.author | Kim, Sungmin | - |
| dc.contributor.author | Cha, Hyejung | - |
| dc.contributor.author | Cho, Oyeon | - |
| dc.contributor.author | Choi, Jin Hwa | - |
| dc.contributor.author | Kim, Myungsoo | - |
| dc.contributor.author | Kim, Juree | - |
| dc.contributor.author | Kim, Tae Gyu | - |
| dc.contributor.author | Yeo, Seung-Gu | - |
| dc.contributor.author | Chang, Ah Ram | - |
| dc.contributor.author | Ahn, Sung-Ja | - |
| dc.contributor.author | Choi, Jinhyun | - |
| dc.contributor.author | Kang, Ki Mun | - |
| dc.contributor.author | Kwon, Jeanny | - |
| dc.contributor.author | Koo, Taeryool | - |
| dc.contributor.author | Kim, Mi Young | - |
| dc.contributor.author | Choi, Seo Hee | - |
| dc.contributor.author | Jeong, Bae Kwon | - |
| dc.contributor.author | Jang, Bum-Sup | - |
| dc.contributor.author | Jo, In Young | - |
| dc.contributor.author | Lee, Hyebin | - |
| dc.contributor.author | Kim, Nalee | - |
| dc.contributor.author | Park, Hae Jin | - |
| dc.contributor.author | Im, Jung Ho | - |
| dc.contributor.author | Lee, Sea-Won | - |
| dc.contributor.author | Cho, Yeona | - |
| dc.contributor.author | Lee, Sun Young | - |
| dc.contributor.author | Chang, Ji Hyun | - |
| dc.contributor.author | Chun, Jaehee | - |
| dc.contributor.author | Lee, Eung Man | - |
| dc.contributor.author | Kim, Jin Sung | - |
| dc.contributor.author | Shin, Kyung Hwan | - |
| dc.contributor.author | Kim, Yong Bae | - |
| dc.date.accessioned | 2023-12-18T02:00:41Z | - |
| dc.date.available | 2023-12-18T02:00:41Z | - |
| dc.date.issued | 2024-02 | - |
| dc.identifier.issn | 0960-9776 | - |
| dc.identifier.issn | 1532-3080 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/68810 | - |
| dc.description.abstract | Purpose: To quantify interobserver variation (IOV) in target volume and organs-at-risk (OAR) contouring across 31 institutions in breast cancer cases and to explore the clinical utility of deep learning (DL)-based auto-contouring in reducing potential IOV. Methods and materials: In phase 1, two breast cancer cases were randomly selected and distributed to multiple institutions for contouring six clinical target volumes (CTVs) and eight OAR. In Phase 2, auto-contour sets were generated using a previously published DL Breast segmentation model and were made available for all participants. The difference in IOV of submitted contours in phases 1 and 2 was investigated quantitatively using the Dice similarity coefficient (DSC) and Hausdorff distance (HD). The qualitative analysis involved using contour heat maps to visualize the extent and location of these variations and the required modification. Results: Over 800 pairwise comparisons were analysed for each structure in each case. Quantitative phase 2 metrics showed significant improvement in the mean DSC (from 0.69 to 0.77) and HD (from 34.9 to 17.9 mm). Quantitative analysis showed increased interobserver agreement in phase 2, specifically for CTV structures (5–19 %), leading to fewer manual adjustments. Underlying IOV differences causes were reported using a questionnaire and hierarchical clustering analysis based on the volume of CTVs. Conclusion: DL-based auto-contours improved the contour agreement for OARs and CTVs significantly, both qualitatively and quantitatively, suggesting its potential role in minimizing radiation therapy protocol deviation. © 2023 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Churchill Livingstone | - |
| dc.title | Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study | - |
| dc.type | Article | - |
| dc.publisher.location | 스코트랜드 | - |
| dc.identifier.doi | 10.1016/j.breast.2023.103599 | - |
| dc.identifier.scopusid | 2-s2.0-85177863148 | - |
| dc.identifier.wosid | 001126091100001 | - |
| dc.identifier.bibliographicCitation | Breast, v.73 | - |
| dc.citation.title | Breast | - |
| dc.citation.volume | 73 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
| dc.subject.keywordPlus | MODULATED RADIATION-THERAPY | - |
| dc.subject.keywordPlus | PHASE-3 RANDOMIZED-TRIAL | - |
| dc.subject.keywordPlus | LYMPH-NODE IRRADIATION | - |
| dc.subject.keywordPlus | CONSENSUS GUIDELINE | - |
| dc.subject.keywordPlus | QUALITY-ASSURANCE | - |
| dc.subject.keywordPlus | RADIOTHERAPY | - |
| dc.subject.keywordPlus | SEGMENTATION | - |
| dc.subject.keywordPlus | VARIABILITY | - |
| dc.subject.keywordPlus | ONCOLOGY | - |
| dc.subject.keywordPlus | IMPACT | - |
| dc.subject.keywordAuthor | Auto-contouring | - |
| dc.subject.keywordAuthor | Breast cancer | - |
| dc.subject.keywordAuthor | Deep learning | - |
| dc.subject.keywordAuthor | Inter-observer variation | - |
| dc.subject.keywordAuthor | RTQA | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
